[glenn1919]

ERNA................................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783

[tw0122]

Ernexa’s technology transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), which are a specialized type of stem cell that has a unique ability to migrate toward tumors or inflammation. Ernexa’s allogeneic synthetic iMSCs allow for enhanced predictability at scale, helping to avoid the challenges of immune rejection and donor shortages.Ernexa has two cell therapy products in development, which are undergoing preclinical trials. Its lead cell therapy product, ERNA-101, is engineered to enhance and regulate the immune system’s response, enabling it to identify and eliminate cancer cells. ERNA-102 is designed to combat inflammation and treat autoimmune disease.ERNA-101 is being developed for the treatment of ovarian cancer as its first indication. There is a significant unmet need in ovarian cancer, which currently lacks highly effective, widely applicable targeted therapies. Many patients develop resistance to the standard treatment in ovarian cancer – platinum-based chemotherapy. Other treatments have been developed but with little success.ERNA-101 and ERNA-102 have the potential to bring significant hope in the treatments of ovarian cancer and autoimmune disease, respectively.Ernexa’s ticker symbol will remain as ERNA.

[glenn1919]

ERNA....................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783

[tw0122]

Getting rid of .33/34 half out .70 almost all out .93 

[glenn1919]

erna...............................https://stockcharts.com/h-sc/ui?s=erna&p=W&b=5&g=0&id=p86431144783

[glenn1919]

ERNA..............................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783

[tw0122]

.33/34 at .27 average this round 

[glenn1919]

erna.......................https://stockcharts.com/h-sc/ui?s=erna&p=W&b=5&g=0&id=p86431144783

[Fairgrounds]

.3256

[tw0122]

.30 +
20%

[tw0122]

.32 the .20s will pay off

[tw0122]

$26-.27s looking better at .28

[tw0122]

Back in at .28 and they halt it

[tw0122]

The power of loading heavy at .28 beat down pays off

[tw0122]

Add .28s how low can she go longer term play perhaps 

[tw0122]

Back in at .30-.31 beat down price 

[glenn1919]

ERNA........................................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783

[tw0122]

70% profit out in .70s  paid off to load .40s

[tw0122]

Add.40-.42

[tw0122]

Back in .45 still have share buyback in place 

[tw0122]

.63 once it floats through weak resistance at .69-.71 off to dollar land $1

[tw0122]

.60 ..Even better off to $1 where it was last week 

[tw0122]

.55 now looking better

[tw0122]

In on .4999s hopefully bottom in at .51

[glenn1919]

ERNA.......................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783

.

....................thx.....lost in the shuffle again..................

[tw0122]

1 million share buyback on this 2 million floater going to skyrocket..😵🥴🚀🚀🚀🚀🚀🚀🚀🚀

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program

November 25 2024 - 8:30AM

[tw0122]

Right back to $1s with announcement...91- 1.28 next profit zone.. The effective date of the reverse stock split has not yet been determined and will be announced by the Company at least two business days prior to its implementation.

[tw0122]

Board is retarded you can't comment on DDC without getting permission to start board 

[Invest-in-America]

ERNA: Yep, been scrutinizing that puppy tonight. (And comment about DDC???)

[tw0122]

Cooling down $1.10 + 31%

[Invest-in-America]

ERNA: Up circa 46% in the Post-Market right now --- likely continued reaction to regaining NASDAQ compliance, YESTERDAY.

[glenn1919]

ERNA.........................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783